Smead Capital Management’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-370,751
Closed -$38.3M 33
2021
Q2
$38.3M Buy
370,751
+43,031
+13% +$4.38M 1.34% 26
2021
Q1
$29.1M Buy
327,720
+27,007
+9% +$2.5M 1.28% 27
2020
Q4
$28.3M Sell
300,713
-13,158
-4% -$1.16M 1.64% 25
2020
Q3
$27.2M Buy
313,871
+121,367
+63% +$10.1M 1.72% 25
2020
Q2
$15.5M Buy
+192,504
New +$15.3M 0.98% 26

Other funds holding CRI

Smead Capital Management's CRI Position: Q3 2021 in Review

Smead Capital Management sold out of Carter's (CRI) in Q3 2021, closing a stake of 370,751 shares — an estimated $38.3M sold.

Smead Capital Management first reported a position in CRI in Q2 2020 and held it in 5 quarters. The position peaked at $38.3M in Q2 2021. 287 funds tracked by Wall St. Rank hold CRI as of Q3 2021.

  • Smead Capital Management reported no remaining Carter's position as of Q3 2021 after selling out during the quarter.
  • Smead Capital Management sold 370,751 Carter's shares in Q3 2021, an estimated $38.3M.
  • Smead Capital Management first reported a position in Carter's in Q2 2020 and held it in 5 quarters.
  • Smead Capital Management's Carter's position peaked at $38.3M in Q2 2021.
  • 287 funds tracked by Wall St. Rank held Carter's as of Q3 2021.

Based on Smead Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.